Our first spotlight session starts in just 3 hours! Hear from Illumina experts on recent developments and future expansions to the TruSight™ Oncology portfolio, including our recently FDA-approved TruSight Oncology Comprehensive. 🧪

A recent peer-reviewed paper from From the Labs at Baylor College of Medicine in Nature Biotechnology highlights the comprehensiveness, accuracy, and scalability of Illumina DRAGEN germline algorithms. Its targeted callers show far fewer false negatives and false positive results versus eight others, and we want

In the fight against blood cancers, traditional tests often fall short, leaving critical mutations undetected. WGS is changing that—offering a single, comprehensive solution with 100% sensitivity for key mutations like FLT3-ITD in Acute Myeloid Leukemia. As #ASH24 approaches,

Just how simple is the MiSeq i100 Series to use? Sireesha Lujan, Global Training & Development Scientist, will show you!

Dylan Mooijman, PhD and his team at Single Cell Discoveries revolutionized the way they work with the help of the NovaSeq X, taking on projects with millions of cells in a single experiment for their customers. Learn how the NovaSeq X is enabling multiomic experiments of the future:

The NovaSeq X single flow cell system began shipping last month alongside new 25B 100-cycle, 200-cycle kits and new, upgraded software for all systems. These new 25B kits will be key enablers of multiomic applications and provide flexibility in run size and cycle counts to

Introducing Illumina Single-Cell 3’ RNA Prep, formerly Fluent PipSeq V, now available and shipping to customers globally. Compatible with all Illumina platforms, Illumina Single-Cell Prep provides a highly efficient, affordable, and accurate workflow for single-cell analysis with

Today on Bloomberg TV, our CEO Jacob Thaysen discussed the company’s transformation and how our strategy is driving the advances that our customers need—from reducing the cost of sequencing, to unlocking multiomic insights, and accelerating AI and informatics solutions. View the

Single-cell sequencing was a niche academic field a decade ago, and it took the global community years to process a million cells. Now with the high-throughput power of the NovaSeq X, the team at Single Cell Discoveries can do it in a weekend. CEO Mauro Muraro and his team share how

📅 29-30th January 📍 ExCeL London ❓ A diverse array of topics beyond genomics, including infectious diseases, proteomics, multi-omics, single-cell & spatial analysis to be discussed ➡️ Learn more and register here: ilmn.ly/40tAp8i

We’re hosting a session on the Main Stage The Festival of Genomics & Biodata – join us for “The Rare Disease Multiomics Programme at Genomic England” 30th January at 9.30am #FoG2025

In 2025, #informatics will be key to unlocking NGS potential. Our Head of Global Software and Informatics Rami Mehio explains in Genetic Engineering & Biotechnology News how data organization, advanced algorithms and AI models will drive the next wave of genomics breakthroughs. Read here: bit.ly/3EjDrTG

Meet Shane Liddelow 🍊, a neuroscientist at NYU Langone Health who is using the new Illumina Single Cell 3’ Prep to investigate a challenging target: astrocytes. With the flexibility of our new technology, the team can sequence 2,000 cells just as easily as 200,000—and it allows them

Illumina is making hematologic cancer research more accessible with Connected Insights v5.1 + DRAGEN v4.3—a powerful, single-vendor solution for advanced genomic analysis. Learn more: bit.ly/3CQ0sgN

Introducing Illumina spatial technology. Enabled on Illumina sequencers and a new multimodal analysis platform, this technology will empower researchers to map complex tissues and understand cellular behavior at unprecedented scale. Scientists can examine the spatial proximity of

We're expanding our multiomics portfolio with game-changing spatial technology that delivers cellular resolution and breadth of coverage – without the compromise. Read Julianna LeMieux PhD’s article in Genetic Engineering & Biotechnology News's of how we're making spatial biology more accessible: bit.ly/41rt3Bx

Want to know more about the latest Illumina innovations & roadmap? Get ready for an afternoon series of talks and hear from the users that have tested the latest innovations like Constellation, spatial etc! Detailed agenda here: ​ilmn.ly/4bhkLjP bit.ly/4kzdDns

Roughly one in eight adults in the United States have used a glucagon-like peptide-1 (GLP-1) receptor agonist, but studies show that almost 40% do not respond effectively to treatment. We're launching a dataset to enable better understanding the molecular basis of GLP-1 therapy

Today, we unveiled PromoterAI, a groundbreaking algorithm that, for the first time at scale, accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. In a study published today in Science Magazine, researchers report a 6% increase

🚀 It’s launch day: Illumina Protein Prep is now available for everyone. 9.5k protein targets. All in one panel. Welcome to the cutting edge of NGS-based proteomics. Get the full scoop ➡️ bit.ly/3VucJgx